SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (484)3/12/2001 10:13:54 AM
From: tuck  Read Replies (1) of 1784
 
Trickle holding BDAL makes a proteomics deal along with two of its sister companies. It supplies mass specs to and makes an equity investment in Integrative Proteomics, a privately held company led by ex-Aurora knowledge officer John Mendlein.

Message 15485898

Hopefully Integrative will IPO in better times, giving BDAL some earnings help when BDAL dumps Integrative's stock.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext